Display Settings:

Format

Send to:

Choose Destination
    Genome Res. 1999 Sep;9(9):859-67.

    High-throughput isolation of Caenorhabditis elegans deletion mutants.

    Source

    Axys Pharmaceuticals, NemaPharm Group, South San Francisco, California 94080, USA. lliu@cambriabio.com

    Abstract

    The nematode Caenorhabditis elegans is the first animal whose genome is completely sequenced, providing a rich source of gene information relevant to metazoan biology and human disease. This abundant sequence information permits a broad-based gene inactivation approach in C. elegans, in which chemically mutagenized nematode populations are screened by PCR for deletion mutations in a specific targeted gene. By handling mutagenized worm growth, genomic DNA templates, PCR screens, and mutant recovery all in 96-well microtiter plates, we have scaled up this approach to isolate deletion mutations in >100 genes to date. Four chemical mutagens, including ethyl methane sulfonate, ethlynitrosourea, diepoxyoctane, and ultraviolet-activated trimethylpsoralen, induced detectable deletions at comparable frequencies. The deletions averaged approximately 1400 bp in size when using a approximately 3 kb screening window. The vast majority of detected deletions removed portions of one or more exons, likely resulting in loss of gene function. This approach requires only the knowledge of a target gene sequence and a suitable mutagen, and thus provides a scalable systematic approach to gene inactivation for any organism that can be handled in high density arrays.

    PMID:
    10508845
    [PubMed - indexed for MEDLINE]
    PMCID: PMC310813
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Figure 2
    Figure 3
    Figure 1

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk